Bo Jin

Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: July 08, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial.

Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 09, 2026

Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study.

Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study.

Journal: The Lancet regional health. Western Pacific

Published: October 30, 2025

Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.

Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.

Journal: Scientific reports

Published: October 08, 2025

Prognostic model of immune -related immune models of ANLN single gene based on TCGA lung adenocarcinoma database.

Prognostic model of immune -related immune models of ANLN single gene based on TCGA lung adenocarcinoma database.

Journal: Discover oncology

Published: September 29, 2025

Downregulation of GNPNAT1 impaired proliferation and correlates with immune infiltration in lung adenocarcinoma.

Downregulation of GNPNAT1 impaired proliferation and correlates with immune infiltration in lung adenocarcinoma.

Journal: Discover oncology

Published: September 29, 2025

The Effect of Astaxanthin on Ochratoxin A-Induced Intestinal Injury in Chickens Through RIPK1/RIPK3/MLKL Pathway.

The Effect of Astaxanthin on Ochratoxin A-Induced Intestinal Injury in Chickens Through RIPK1/RIPK3/MLKL Pathway.

Journal: Antioxidants (Basel, Switzerland)

Published: June 22, 2025

Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial.

Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial.

Journal: Lancet (London, England)

Published: June 11, 2025

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.

Journal: The Lancet. Respiratory medicine

Published: February 19, 2025

A transformer-based framework for temporal health event prediction with graph-enhanced representations.

A transformer-based framework for temporal health event prediction with graph-enhanced representations.

Journal: Journal of biomedical informatics

Published: December 17, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026